Stay updated on Atezolizumab Subq in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.

Latest updates to the Atezolizumab Subq in NSCLC: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now displays a generic 'An error occurred' message and HTML, replacing the previous study record content. This indicates a temporary outage or server error rather than an update to the study data.SummaryDifference18%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision changed from v3.6.3 to v3.6.4, indicating a minor update to the page's version metadata. This update does not alter any study details, eligibility criteria, or results on the page.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a new publication citation for subcutaneous vs intravenous atezolizumab in NSCLC and removed the prior online-ahead-of-print citation, updating the referenced literature in the Publications section.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision label on the page has been updated from v3.6.0 to v3.6.2, indicating a minor update to the page template or content rather than to the study information.SummaryDifference0.0%

- Check73 days agoChange DetectedThe Intervention/Treatment section label is updated and new guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study have been added, while a status line No longer looking for participants appears on the page.SummaryDifference0.2%

- Check80 days agoChange DetectedA new publication citation by Burotto et al. is added to the study record, and the revision version is updated to v3.5.5. The previous revision v3.5.4 is removed.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab Subq in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.